Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Post by Realistic11on Jan 12, 2019 1:15pm

178 Views

Post# 29223158

PENNY THE PAID PUMPER

Have a small position, taking interest in the NR 12/20/18. After the NR of yesterday, did some DD. This stock has been a sinking ship for the last year. I put in a sell order today for Monday, getting out of this dog! As for Penny, after reviewing her posting history, I agree with others on this board. She is a paid pumper, working for a broker. If she is on a commission based on replies, instead of minimum wage, she is making a bundle off the many here. Don't feed into her BS, she is the lowest form of life!! IMHO

Bullboard Posts

The investment impact of the U.S. 25% tariff on Canadian imports